Significant Ownership of Datuk Dr. Doris Wong Sing Ee
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Datuk Dr. Doris Wong Sing Ee focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Datuk Dr. Doris Wong Sing Ee - Chief Executive Officer and Executive Director
- Manager location
- Wilayahpersekutuankuala Lumpur, Malaysia
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Datuk Dr. Doris Wong Sing Ee with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Datuk Dr. Doris Wong Sing Ee
Significant Ownership of Datuk Dr. Doris Wong Sing Ee
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 70% | $58,388,646 | 194,628,820 | Doris Wong Sing Ee | 26 Feb 2025 | ||
| BGMS | Bio Green Med Solution, Inc. | Common Stock, par value $0.0001 per share | 21% | $5,555,655 | 1,111,131 | Doris Wong Sing Ee | 12 Nov 2025 |
Schedules 13D/G Reported by Datuk Dr. Doris Wong Sing Ee:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.